We leveraged bioinformatics methodologies in conjunction with numerous publicly available databases to unravel the potential oncogenic significance of IQGAP3 in gliomas, including its expression, diagnostic, prognostic, genetic alterations, immune cell infiltration, and targeted drugs. Here, IQGAP3 is linked to central nervous system cancer.